About Cycle Pharma
Cycle Pharma is a company based in Cambridge (United Kingdom) founded in 2012. The company has 54 employees as of December 31, 2021. Cycle Pharma has completed 2 acquisitions, including Applied Therapeutics and Banner Life Sciences. Cycle Pharma offers products and services including Cycle Vita and VENXXIVA. Cycle Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Alnylam, among others.
- Headquarter Cambridge, United Kingdom
- Employees 54 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cycle Pharmaceuticals Ltd
- Date of Incorporation 02 Feb, 2012
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
$30.23 M (USD)31as on Dec 31, 2020
-
Net Profit
$10.71 M (USD)67as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
$25 M (USD), Debt – Conventional
Sep 07, 2020
- Investors
-
Employee Count
54
as on Dec 31, 2021
-
Investments & Acquisitions
Applied Therapeutics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cycle Pharma
Cycle Pharma offers a comprehensive portfolio of products and services, including Cycle Vita and VENXXIVA.
AI-powered app for managing rare diseases like PKU.
Tablets for treating cystinuria and reducing pill burden.
People of Cycle Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Cycle Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $25.0M
-
First Round
First Round
(07 Sep 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Debt – Conventional - Cycle Pharma | Valuation |
investors |
Investors in Cycle Pharma
Cycle Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Deutsche Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified banking and financial services are provided globally.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cycle Pharma
Cycle Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Applied Therapeutics and Banner Life Sciences.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drugs for metabolic and cardiovascular diseases are developed.
|
2015 | ||||
|
Fully integrated product development using its formulation technologies.
|
1994 |
Financial Statements - Cycle Pharma
Cycle Pharma Comparisons
Competitors of Cycle Pharma
Cycle Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Alnylam, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
Frequently Asked Questions about Cycle Pharma
Cycle Pharma was founded in 2012 and raised its 1st funding round 8 years after it was founded.
Cycle Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
As of Dec 31, 2021, the latest employee count at Cycle Pharma is 54.
Annual revenue of Cycle Pharma is $30.23M as on Dec 31, 2020.
Cycle Pharma was founded in 2012 and is based in Cambridge, United Kingdom. Operations focus on biopharmaceutical development, including reformulation and repurposing of small molecule drugs for orphan diseases. FDA approval was granted in August 2017 for NITYR (nitisinone tablets), used to treat Hereditary Tyrosinemia type 1, with a formulation that avoids refrigeration and allows dissolution in water for pediatric use. Generics are also manufactured by the company.
Cycle Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Cycle Pharma offers Cycle Vita and VENXXIVA.
Cycle Pharma has made 2 acquisitions, including Applied Therapeutics, and Banner Life Sciences.
Cycle Pharma has 1 investor. Key investors include Deutsche Bank.